Table 1.

Expanded model for predicting chemotherapy-associated thrombosis.

Patient characteristics	VTE risk score
Site of cancer
Very high risk (primary brain, stomach or pancreas)	2
High risk (lung, lymphoma, gynecologic, genitourinary excluding prostate or multiple myeloma)	1
Low risk (breast, colorectal or head and neck)	0
Other characteristics
Platelet count ≥350 × 109/l	1
Hemoglobin <100 g/l or use of red blood cell growth factors	1
Leukocyte count >11 × 109/l	1
BMI ≥35 kg/m2	1
sP-selectin ≥53.1 ng/ml	1
D-dimer ≥1.44 μg/ml	1

sP-selectin: Soluble P-selectin; VTE: Venous thromboembolism.

Reproduced with permission from [37].